维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Patsopoulos"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	CYP2D6 polymorphisms and the risk of tardive dys- kinesia in schizophrenia: a meta-analysis显示文摘	Patsopoulos NA Ntzani EE Zintzaras E	2005	Phar- macogenet Genomies2005，15，3：	1
2	Reasons or excuses for avoiding meta - analysis in forest plots 显示文摘	Ioannidis JP Patsopoulos NA Rothstein HR	2008	BMJ2008，336，7658：	1
3	Fine-mapping classical HLA variation associated with durable host control of HIV-1infection in African Americans显示文摘	McLaren P J Ripke S Pelak K Weintrob A C Patsopoulos N A Jia X Erlich R L Lennon N J Kadie C M Heckerman D Gupta N Haas D W Deeks S G Pereyra F Walker B D de Bakker P I International HIV Controllers Study	2012	Hum Mol Genet2012，21，19：	1
4	Industry sponsorship and selection of comparators in randomized clinical trials显示文摘	Lathyris DN Patsopoulos NA Salanti G	2010	Eur J Clin Invest2010，40，：	1
5	Uncertainty in heterogeneity estimates in meta-analyses显示文摘	Ioannidis JP Patsopoulos NA Evangelou E		0，，7626：	1
6	Research methodology:reasons or excuses for avoiding meta-analysis in forest plots显示文摘	Ioannidis JP Patsopoulos NA Rothstein HR	2008	BMJ2008，336，7658：	1
7	Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials显示文摘	Valachis A Polyzos NP Patsopoulos NA	2010	Breast Cancer Res Treat2010，122，1：	1
8	Relative citation impact of various study designs in the health sciences显示文摘	Patsopoulos N A Analatos A A Ioannidis J P A	2005	JAMA2005，293，19：	1
9	CYP2D6 polymorphisms and the risk of tardive dyskinesla in schizophrenia : a meta-analysis 显示文摘	Nikolaos A Patsopoulos Evangelia E	2005	Pharmacogenetics and Genomics2005，15，：	1
10	Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci:a recta-analysis 显示文摘	Patsopoulos NA loannidis JP	2010	Ann Rheum Dis2010，69，3：	1
11	Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation 显示文摘	Patsopoulos N A Evangelos E Ioannidis J P	2008	International Journal of Epidemiology2008，37，5：	1
12	Bevacizumab in metastatic breast cancer:a meta-analysis of randomized controlled trials显示文摘	Valachis A Polyzos N P Patsopoulos N A		0，，01：	1
13	Reasons or excuses for avoiding recta-analysis in forest plots 显示文摘	Ioannidis JP Patsopoulos NA Rothstein HR	2008	BMJ2008，336，7658：	1
14	Effect of geneticvariants, especially CYP2C9 and VKORC1,on the pharmacologyof warfarin显示文摘	Fung E Patsopoulos NA Belknap SM	2012	Semin Thromb Hemost2012，38，：	1
15	Sensitivity of be- tween-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation显示文摘	Patsopoulos NA Evangelou E Ioannidis JP	2008	Int J Epidemiol2008，37，5：	1
16	Research Methodolo- gy: Reasons or excuses for avoiding meta - analysis in forest plots 显示文摘	Ioannidis JPA Patsopoulos NA Rothstein HR	2008	BMJ2008，336，7658：	1
17	Heterogeneity in meta-analyses of genome-wide association investigations显示文摘	Ioannidis JP Patsopoulos NA Evangelou E	2007	PLoS One2007，2，9：	1
18	Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials显示文摘	Valachis A Polyzos NP Patsopoulos NA	2010	Breast Cancer Res Treat2010，122，1：	1
19	Bevacizumab in metastatic breast cancer:a meta-analysis of randomized controlled trials显示文摘	Valachis A Polyzos NP Patsopoulos NA	2010	Breast Cancer Res Treat2010，122，1：	1
20	Bevacizumab in metastatic breast cancer:a meta-a-nalysis of randomized controlled trials显示文摘	Valachis A Polyzos NP Patsopoulos NA		0，，01：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示